Cargando…
Cardiovascular disease after cancer therapy
Improvements in treatment and earlier diagnosis have both contributed to increased survival for many cancer patients. Unfortunately, many treatments carry a risk of late effects including cardiovascular diseases (CVDs), possibly leading to significant morbidity and mortality. In this paper we descri...
Autores principales: | Aleman, Berthe M.P., Moser, Elizabeth C., Nuver, Janine, Suter, Thomas M., Maraldo, Maja V., Specht, Lena, Vrieling, Conny, Darby, Sarah C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250533/ https://www.ncbi.nlm.nih.gov/pubmed/26217163 http://dx.doi.org/10.1016/j.ejcsup.2014.03.002 |
Ejemplares similares
-
Long‐term hospitalisation rates among 5‐year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study
por: Rugbjerg, Kathrine, et al.
Publicado: (2017) -
Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold
por: Rechner, Laura Ann, et al.
Publicado: (2017) -
Proton Therapy For Lymphomas: Current State Of The Art
por: Ricardi, Umberto, et al.
Publicado: (2019) -
Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years
por: Jacobse, Judy N., et al.
Publicado: (2019) -
Biological optimization for mediastinal lymphoma radiotherapy – a preliminary study
por: Rechner, Laura Ann, et al.
Publicado: (2020)